Adult outpatients with mild symptoms of COVID-19 don’t benefit from taking hydroxychloroquine
Early treatment trial of hydroxychloroquine shows no symptomatic benefit for COVID-19 patients_1.png
New study by RI-MUHC researchers first to establish that physiological signals influence circadian rhythms
Congratulations to researchers and trainees!
New publication links neutrophil infiltration in the lungs of patients to COVID-19 symptoms
—
20 Items per Page